{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:39:49Z","timestamp":1786981189654,"version":"build-2736575974"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10787-023-01242-9","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:02:45Z","timestamp":1695826965000},"page":"2781-2797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases"],"prefix":"10.1007","volume":"31","author":[{"given":"I.","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. D.","family":"Rainsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-0449","authenticated-orcid":false,"given":"Joel S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"1242_CR4","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.2174\/1381612820666140130204401","volume":"20","author":"HO Besedovsky","year":"2014","unstructured":"Besedovsky HO, Rey AD (2014) Physiologic versus diabetogenic effects of interleukin- 1: a question of weight. Curr Pharm Des 20:4733\u20134740","journal-title":"Curr Pharm Des"},{"issue":"12","key":"1242_CR7","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.2337\/dc14-0961","volume":"37","author":"BM Brooks-Worrell","year":"2014","unstructured":"Brooks-Worrell BM, Boyko EJ, Palmer JP (2014) Impact of islet autoimmunity on the progressive \u03b2-cell functional decline in type 2 diabetes. Diabetes Care 37(12):3286\u20133293","journal-title":"Diabetes Care"},{"issue":"8","key":"1242_CR8","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.2337\/dc11-2219","volume":"35","author":"C Cavelti-Weder","year":"2012","unstructured":"Cavelti-Weder C et al (2012) Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35(8):1654\u20131662","journal-title":"Diabetes Care"},{"issue":"331","key":"1242_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"2011","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM et al (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011(331):456\u2013461","journal-title":"Science"},{"issue":"4","key":"1242_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2012.01.023","volume":"15","author":"K Eguchi","year":"2012","unstructured":"Eguchi K et al (2012) Saturated fatty acid and TLR signaling link \u03b2 cell dysfunction and islet inflammation. Cell Metab 15(4):518\u2013533","journal-title":"Cell Metab"},{"issue":"9","key":"1242_CR13","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db06-1650","volume":"56","author":"JA Ehses","year":"2007","unstructured":"Ehses JA et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56(9):2356\u20132370","journal-title":"Diabetes"},{"issue":"33","key":"1242_CR14","doi-asserted-by":"publisher","first-page":"13998","DOI":"10.1073\/pnas.0810087106","volume":"106","author":"JA Ehses","year":"2009","unstructured":"Ehses JA et al (2009) IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 106(33):13998\u201314003","journal-title":"Proc Natl Acad Sci USA"},{"key":"1242_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/er.2007-0015","volume":"29","author":"D Eizirik","year":"2008","unstructured":"Eizirik D, Cardozo A, Nop C (2008) The role of endoplsmkci reticulum stress in diabetes mellitus. Endocrine Rev 29:42\u201361","journal-title":"Endocrine Rev"},{"issue":"6","key":"1242_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4158\/EP12064.OR","volume":"18","author":"E Faghihimani","year":"2012","unstructured":"Faghihimani E, Aminorroaya A, Rezvanian H et al (2012a) Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes. Endocr Pract 18(6):826\u2013833","journal-title":"Endocr Pract"},{"issue":"2","key":"1242_CR17","first-page":"40","volume":"2013","author":"E Faghihimani","year":"2012","unstructured":"Faghihimani E, Amini M, Adibi A et al (2012b) Evaluating the efficacy of salsalate on prediabetic and diabetic patients with fatty liver: a randomized clinical trial. J Res Pharm Pract 2013(2):40\u201343","journal-title":"J Res Pharm Pract"},{"issue":"1","key":"1242_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11596-013-1063-5","volume":"33","author":"F Fang","year":"2013","unstructured":"Fang F, Lu Y, Ma DL et al (2013) A meta-analysis of salicylates for type 2 diabetes mellitus. J Huazhong Univ Sci Technolog Med Sci 33(1):1\u201314","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"1242_CR19","doi-asserted-by":"publisher","first-page":"26055","DOI":"10.1016\/S0021-9258(19)74276-8","volume":"268","author":"R. Feinstein","year":"1993","unstructured":"Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumor necrosisfactor-\u03b1 suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055\u201326058","journal-title":"J Biol Chem"},{"key":"1242_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1055\/s-0031-1287783","volume":"43","author":"I Ferraz-Amaro","year":"2011","unstructured":"Ferraz-Amaro I, Arce-Franco M, Muniz J et al (2011) Systemic blockade of TNF-alpha does not improve insulin resistance in humans. Horm Metab Res 43:801\u2013808","journal-title":"Horm Metab Res"},{"issue":"2","key":"1242_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2337\/dc07-1338","volume":"31","author":"A Fleischman","year":"2008","unstructured":"Fleischman A, Shoelson SE, Bernier R et al (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31(2):289\u2013294","journal-title":"Diabetes Care"},{"issue":"17","key":"1242_CR23","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Garcia","year":"2020","unstructured":"Garcia U, Vicente A, Jebari S et al (2020) Pathophysiology of type 2 diabetes melliuts. Int J Mol Sci 21(17):6275","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1242_CR127","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","volume":"1","author":"AB Goldfine","year":"2008","unstructured":"Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, Shoelson SE (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 1(1):36\u201344","journal-title":"Clin Transl Sci"},{"issue":"1","key":"1242_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/2011\/360312","volume":"30","author":"JM Guzman-Flores","year":"2011","unstructured":"Guzman-Flores JM, Munoz-Valle JF, Sanchez-Corona J et al (2011) Tumor necrosis factor-alpha gene promoter \u2212308G\/A and \u2212238G\/A polymorphisms in Mexican patients with type 2 diabetes mellitus. Dis Markers 30(1):19\u201324","journal-title":"Dis Markers"},{"key":"1242_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/oby.20004","volume":"21","author":"M Handa","year":"2013","unstructured":"Handa M, Vanegas S, Maddux BA et al (2013) XOMA 052, an anti-IL-1beta monoclonal antibody, prevents IL-1beta-mediated insulin resistance in 3T3-L1 adipocytes. Obesity (silver Spring) 21:306\u2013309","journal-title":"Obesity (silver Spring)"},{"key":"1242_CR31","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/db13-0368","volume":"62","author":"DG Hardie","year":"2013","unstructured":"Hardie DG (2013) AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62:2164\u20132172","journal-title":"Diabetes"},{"issue":"4","key":"1242_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jamacardio.2016.0605","volume":"11","author":"TH Hauser","year":"2016","unstructured":"Hauser TH, Salastekar N, Schaefer EJ, Desai T, Goldfine HL, Fowler KM, Weber GM, Welty F, Clouse M, Shoelson SE, Goldfine AB (2016) Targeting inflammation using salsalate in cardiovascular disease (TINSAL-CVD) Study team. Effect of targeting Inflammation With salsalate: the TINSAL-CVD randomized clinical trial on progression of coronary plaque in overweight and obese patients using statins. JAMA Cardiol. 11(4):413\u2013423","journal-title":"JAMA Cardiol."},{"issue":"336","key":"1242_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1126\/science.1215327","volume":"2012","author":"SA Hawley","year":"2012","unstructured":"Hawley SA, Fullerton MD, Ross FA et al (2012) The ancient drug salicylate directly activates AMP-activated protein kinase. Science 2012(336):918\u2013922","journal-title":"Science"},{"key":"1242_CR34","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.ajpath.2013.02.032","volume":"182","author":"L He","year":"2013","unstructured":"He L, Marneros AG (2013) Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. Am J Pathol 182:2407\u20132417","journal-title":"Am J Pathol"},{"issue":"39","key":"1242_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.diabet.2013.07.003","volume":"2013","author":"J Hensen","year":"2013","unstructured":"Hensen J, Howard CP, Walter V et al (2013) Impact of interleukin-1beta antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial. Diabetes Metab 2013(39):524\u2013531","journal-title":"Diabetes Metab"},{"key":"1242_CR36","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1101\/gad.7.11.2135","volume":"7","author":"M. Hibi","year":"1993","unstructured":"Hibi M, Lin A, Smeal T, Minden A, Karin M (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135\u20132148","journal-title":"Genes Dev"},{"issue":"7121","key":"1242_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS. Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860\u2013867","journal-title":"Nature"},{"key":"1242_CR40","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","volume":"43","author":"GS Hotamisligil","year":"1994","unstructured":"Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor alpha: a key component of the besity-diabetes link. Diabetes 43:1271\u20131278","journal-title":"Diabetes"},{"key":"1242_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance. Science 259:87\u201391","journal-title":"Science"},{"issue":"13","key":"1242_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1475-2840-13-94","volume":"2014","author":"C Howard","year":"2014","unstructured":"Howard C, Noe A, Skerjanec A et al (2014) Safety and tolerability of canakinumab, an IL-1beta inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies. Cardiovasc Diabetol 2014(13):94","journal-title":"Cardiovasc Diabetol"},{"key":"1242_CR43","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1172\/JCI0214955","volume":"109","author":"RS Hundal","year":"2002","unstructured":"Hundal RS, Petersen KF, Mayerson AB et al (2002a) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321\u20131326","journal-title":"J Clin Invest"},{"key":"1242_CR44","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1172\/JCI0214955","volume":"109","author":"RS Hundal","year":"2002","unstructured":"Hundal RS et al (2002b) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321\u20131326","journal-title":"J Clin Invest"},{"key":"1242_CR45","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.chembiol.2014.05.014","volume":"21","author":"RW Hunter","year":"2014","unstructured":"Hunter RW, Foretz M, Bultot L et al (2014) Mechanism of action of compound-13: an alpha1-selective small molecule activator of AMPK. Chem Biol 21:866\u2013879","journal-title":"Chem Biol"},{"key":"1242_CR46","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.4049\/jimmunol.1102154","volume":"188","author":"Y Iwata","year":"2012","unstructured":"Iwata Y, Bostr\u00f6m EA, Menke J, Rabacal WA, Morel L et al (2012) Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice. J Immunol 188:4568\u20134580","journal-title":"J Immunol"},{"key":"1242_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1074\/jbc.M205565200","volume":"278","author":"G Jiang","year":"2003","unstructured":"Jiang G, Dallas-Yang Q, Liu F, Moller DE, Zhang BB (2003) Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA) and tumor necrosis factor \u03b1 (TNF-\u03b1)\u2013induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK 293) cells. J Biol Chem 278:180\u2013186","journal-title":"J Biol Chem"},{"issue":"9","key":"1242_CR48","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/nm.3265","volume":"19","author":"T Jourdan","year":"2013","unstructured":"Jourdan T et al (2013) Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 19(9):1132\u20131140","journal-title":"Nat Med"},{"issue":"3","key":"1242_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/13506129.2014.937857","volume":"21","author":"K Kamata","year":"2014","unstructured":"Kamata K et al (2014) Islet amyloid with macrophage migration correlates with augmented \u03b2-cell deficits in type 2 diabetic patients. Amyloid 21(3):191\u2013220","journal-title":"Amyloid"},{"key":"1242_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/486912","author":"BC Kennedy","year":"2013","unstructured":"Kennedy BC, Showers CR, Anderson DE, Anderson L, Canoll P et al (2013) Tumor-associated macrophages in glioma: friend or foe? J Oncol. https:\/\/doi.org\/10.1155\/2013\/486912","journal-title":"J Oncol"},{"issue":"1","key":"1242_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"M Khan","year":"2020","unstructured":"Khan M, Hashim M, King J, Govendere R, Ustafa J, Kaabi J (2020) Epidemiology of type 2 diabetes-global burden of disease and forecasted trends. J Epidemiol Glob Helath 10(1):107\u2013111","journal-title":"J Epidemiol Glob Helath"},{"key":"1242_CR54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Bs V, Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132\u2013141","journal-title":"Nat Cell Biol"},{"issue":"7","key":"1242_CR55","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.2337\/dc13-2977","volume":"37","author":"SH Kim","year":"2014","unstructured":"Kim SH, Liu A, Ariel D et al (2014) Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study. Diabetes Care 37(7):1944\u20131950","journal-title":"Diabetes Care"},{"key":"1242_CR57","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.8052854","volume":"265","author":"E Kopp","year":"1994","unstructured":"Kopp E., Ghosh S. (1994) Inhibition of NFkappa B by sodium salicylate and aspirin. Science 265:956\u2013959","journal-title":"Science"},{"key":"1242_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","volume":"52","author":"OrtegaE Koska","year":"2009","unstructured":"Koska OrtegaE, Buntl C et al (2009a) The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomized double-blind placebo-controlled study. Diabetologia 52:385\u2013393","journal-title":"Diabetologia"},{"issue":"3","key":"1242_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","volume":"52","author":"J Koska","year":"2009","unstructured":"Koska J, Ortega E, Bunt JC et al (2009b) The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double blind placebo-controlled study. Diabetologia 52(3):385\u2013393","journal-title":"Diabetologia"},{"issue":"6","key":"1242_CR60","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2337\/diacare.26.6.1745","volume":"26","author":"J Krakoff","year":"2003","unstructured":"Krakoff J, Funahashi T, Stehouwer C, Schalkwijk C, Tanaka S, Matsuzawa Y, Kobes S, Tataranni P, Hanson R, Knowler W, Lindsay R (2003) Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26(6):1745\u20131751","journal-title":"Diabetes Care"},{"key":"1242_CR61","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/369156a0","volume":"369","author":"JM Kyriakis","year":"1994","unstructured":"Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F. et al (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156\u2013160","journal-title":"Nature"},{"key":"1242_CR62","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen CM, Faulenbach M, Vaag A et al (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517\u20131526","journal-title":"N Engl J Med"},{"key":"1242_CR64","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM et al (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376\u2013388","journal-title":"Cell Metab"},{"key":"1242_CR65","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2337\/db12-1625","volume":"63","author":"G Lowe","year":"2014","unstructured":"Lowe G, Woodward M, Hillis G et al (2014) Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes 63:1115\u20131123","journal-title":"Diabetes"},{"key":"1242_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","volume":"582","author":"De LucaC","year":"2008","unstructured":"LucaC De, Olefsky M (2008) Inflammation and insulin resistance. FEBS Lett 582:97\u2013105","journal-title":"FEBS Lett"},{"issue":"6","key":"1242_CR67","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","volume":"121","author":"CN Lumeng","year":"2011","unstructured":"Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121(6):2111\u20132117","journal-title":"J Clin Invest"},{"key":"1242_CR68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-3-642-17214-4_11","volume":"203","author":"K Maedler","year":"2011","unstructured":"Maedler K, Dharmadhikari G, Schumann DM et al (2011) Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes. Handb Exp Pharmacol 203:257\u2013278","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"1242_CR71","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2265.2012.04384.x","volume":"78","author":"P. Marques-Vidal","year":"2013","unstructured":"Marques-Vidal P, Bastardot F, Von Kanel R et al (2013) Association \u00a8 between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol 78(2):232\u2013241","journal-title":"Clin Endocrinol"},{"issue":"12","key":"1242_CR72","doi-asserted-by":"publisher","first-page":"E1397","DOI":"10.1152\/ajpendo.00064.2014","volume":"306","author":"TD Martin","year":"2014","unstructured":"Martin TD, Dennis MD, Gordon BS, Kimball SR, Jefferson LS (2014) mTORC1 and JNK coordinate phosphorylation of the p70S6K1 autoinhibitory domain in skeletal muscle following functional overloading. Am J Physiol Endocrinol Metab 306(12):E1397\u2013E1405","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"1242_CR73","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat Immunol 11(10):897\u2013904","journal-title":"Nat Immunol"},{"key":"1242_CR74","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ijo.2013.206","volume":"38","author":"M Matsushita","year":"2013","unstructured":"Matsushita M, Yoneshiro T, Aita S, Kameya T, Sugie H, Saito M (2013) Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans. Int J Obes 38:812\u2013817","journal-title":"Int J Obes"},{"key":"1242_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.08.004","author":"A Noe","year":"2014","unstructured":"Noe A, Howard C, Thuren T et al (2014) Pharmacokinetic and pharmacodynamic characteristics of single-dose canakinumab in patients with type 2 diabetes mellitus. Clin Ther. https:\/\/doi.org\/10.1016\/j.clinthera.2014.08.004","journal-title":"Clin Ther"},{"key":"1242_CR77","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000609","author":"A Nohria","year":"2014","unstructured":"Nohria A, Kinlay S, Buck J et al (2014) The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.113.000609","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1242_CR78","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/acr.22110","volume":"66","author":"A Ogata","year":"2014","unstructured":"Ogata A, Tanimura K et al (2014) Phase III study of the efficacy and safety of subcutaneous versus intravenous toclizumab monotherapy in patients with rheumatoid arthritis. Arthritis Care Res 66(3):344\u2013354","journal-title":"Arthritis Care Res"},{"issue":"5695","key":"1242_CR80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, Cao Q, Yilmaz E, Lee A, Iwakoshi N, Ozdelen E, Tuncman G, Gorgun C, Glimcher L, Hitamisligil G (2004) Endoplasmic reticulum stress links obesity, insulin action and type 2 diabets. Science 306(5695):457\u2013461","journal-title":"Science"},{"key":"1242_CR82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu G-Y et al (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140:197\u2013208","journal-title":"Cell"},{"key":"1242_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/616193","volume":"2013","author":"P Patel","year":"2013","unstructured":"Patel P, Buras E, Balasubramanyam A (2013) The role of the immune system in obesity and insulin resistance. J Obes 2013:616193","journal-title":"J Obes"},{"key":"1242_CR85","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s001250051058","volume":"41","author":"J.C. Pickup","year":"1998","unstructured":"Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241\u20131248","journal-title":"Diabetologia"},{"issue":"10","key":"1242_CR86","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.4049\/jimmunol.156.10.3961","volume":"156","author":"JW Pierce","year":"1996","unstructured":"Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T (1996) Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 156(10):3961\u20133969","journal-title":"J Immunol"},{"key":"1242_CR87","doi-asserted-by":"publisher","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","volume":"95","author":"MH Pillinger","year":"1998","unstructured":"Pillinger MH, Capodici C, Rosenthal P et al (1998) Modesof action of aspirin like drugs:salicylates inhibit Erk activation and integrin-dependent neutrophil adhesion. Proc Nat Acad Sci USA 95:14540\u201314545","journal-title":"Proc Nat Acad Sci USA"},{"key":"1242_CR88","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1194\/jlr.M030528","volume":"54","author":"SL Pinkosky","year":"2013","unstructured":"Pinkosky SL, Filippov S, Srivastava RA et al (2013) AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res 54:134\u2013151","journal-title":"J Lipid Res"},{"key":"1242_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1478-811X-11-29","volume":"11","author":"DT Ploeger","year":"2013","unstructured":"Ploeger DT, Hosper NA, Schipper M, Koerts JA, de Rond S et al (2013) Cell plasticity in wound healing: paracrine factors of M1\/M2 polarized macrophages influence the phenotypical state of dermal fibroblasts. Cell Commun Signal 11:29","journal-title":"Cell Commun Signal"},{"key":"1242_CR90","doi-asserted-by":"crossref","unstructured":"Qiao YC, Shen J, He L, Hong XZ, Tian F, Pan YH, Liang L, Zhang XX, Zhao HL (2016) Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. J Diabetes Res.","DOI":"10.1155\/2016\/3694957"},{"issue":"4","key":"1242_CR92","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/BF00613458","volume":"29","author":"IW Reimann","year":"1985","unstructured":"Reimann IW, Golbs E, Fischer C, Fr\u00f6lich JC (1985) Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance. Eur J Clin Pharmacol 29(4):435\u2013441","journal-title":"Eur J Clin Pharmacol"},{"key":"1242_CR93","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2217\/dmt.12.42","volume":"2","author":"G Rena","year":"2012","unstructured":"Rena G, Pearson ER, Sakamoto K (2012) Molecular action and pharmacogenetics of metformin: current understanding of an old drug. Diabetes Manag 2:439\u2013452","journal-title":"Diabetes Manag"},{"key":"1242_CR95","doi-asserted-by":"publisher","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE\u00a0, Bright D, Williams R. IDF Diabetes Atlas Committee Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th\u00a0edition. Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: https:\/\/doi.org\/10.1016\/j.diabres.2019.107843. Epub 2019 Sep 10.","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"1242_CR96","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen A et al (2011) AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med 89:667\u2013676","journal-title":"J Mol Med"},{"key":"1242_CR97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0962-8924(01)02207-3","volume":"12","author":"AR Saltiel","year":"2002","unstructured":"Saltiel AR, Pessin JE (2002) Insulin signaling pathways in time and space. Trends Cell Biol 12:65\u201371","journal-title":"Trends Cell Biol"},{"issue":"5","key":"1242_CR98","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2007-1059","volume":"149","author":"NS Sauter","year":"2008","unstructured":"Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K (2008) The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149(5):2208\u20132218","journal-title":"Endocrinology"},{"issue":"9165","key":"1242_CR99","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","volume":"353","author":"M.I. Schmidt","year":"1999","unstructured":"Schmidt MI, Duncan BB, Sharrett AR et al (1999a) Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353(9165):1649\u20131652","journal-title":"Lancet"},{"issue":"9165","key":"1242_CR100","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","volume":"353","author":"MI Schmidt","year":"1999","unstructured":"Schmidt MI, Duncan BB, Sharrett AR et al (1999b) Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study\u201d. Lancet 353(9165):1649\u20131652","journal-title":"Lancet"},{"issue":"11","key":"1242_CR101","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrgastro.2013.211","volume":"2014","author":"JL Schneider","year":"2014","unstructured":"Schneider JL, Cuervo AM (2014) Liver autophagy: much more than just taking out the trash. Nat Rev Gastroenterol Hepatol 2014(11):187\u2013200","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1242_CR102","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.1074\/jbc.271.14.8089","volume":"271","author":"J Schwenger","year":"1996","unstructured":"Schwenger J (1996a) Inhibition of tumornecrosis factor-induced mitogen-activated protein kinase activation by sodium salicylate. J Bioi Chern 271:8089\u20138094","journal-title":"J Bioi Chern"},{"key":"1242_CR103","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.1074\/jbc.271.14.8089","volume":"271","author":"J Schwenger","year":"1996","unstructured":"Schwenger J (1996b) Inhibition of tumor necrosis factor\u2013induced mitogen-activated protein kinase activation by sodium salicylate. J Biol Chem 271:8089\u20138094","journal-title":"J Biol Chem"},{"key":"1242_CR104","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.tcb.2014.06.006","volume":"24","author":"C Settembre","year":"2014","unstructured":"Settembre C, Ballabio A (2014) Lysosome: regulator of lipid degradation pathways. Trends Cell Biol 24:743\u2013750","journal-title":"Trends Cell Biol"},{"key":"1242_CR105","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1096\/fj.09-151340","volume":"24","author":"G Solinas","year":"2010","unstructured":"Solinas G, Karin M (2010) JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J 24:2596\u20132611","journal-title":"FASEB J"},{"key":"1242_CR106","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.2011.878","volume":"305","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Massarotti E, Garg R et al (2011) Association between disease modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 305:2525\u20132531","journal-title":"JAMA"},{"issue":"3","key":"1242_CR107","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","volume":"52","author":"J Spranger","year":"2003","unstructured":"Spranger J, Kroke A, Mohlig M, Hoffman K, Bergmann M, Ristow M, Boeing H, Pfeiffer A (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes 52(3):812\u2013817","journal-title":"Diabetes"},{"issue":"9833","key":"1242_CR109","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"A Tabak","year":"2012","unstructured":"Tabak A, Herder C, Rathmann W, Brunner E, Kivimaki M (2012) Prediabetes: a high-risk state for developing diabetes. Lancet 379(9833):2279\u20132290","journal-title":"Lancet"},{"key":"1242_CR110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-065X.2012.01145.x","volume":"249","author":"CJ Tack","year":"2012","unstructured":"Tack CJ, Stienstra R, Joosten LA et al (2012) Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev 249:239\u2013252","journal-title":"Immunol Rev"},{"issue":"1","key":"1242_CR111","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12291-015-0514-0","volume":"31","author":"S Tangvarasittichai","year":"2016","unstructured":"Tangvarasittichai S, Pongthaisong S, Tangvarasittichai O (2016) Tumor necrosis factor-\u0391, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women\u201d. Indian J Clin Biochem 31(1):68\u201374","journal-title":"Indian J Clin Biochem"},{"key":"1242_CR113","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.cca.2012.03.021","volume":"413","author":"A.D. Van Dam","year":"2012","unstructured":"Van Dam AD, Nahon KJ, Kooijman S, Van Den Berg SM, Kanhai AA, Kikuchi T, Heemskerk MM, van Harmelen V et al (2012) Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin Chim Acta 413:1163\u20131170","journal-title":"Clin Chim Acta"},{"issue":"12","key":"1242_CR114","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/dom.12357","volume":"16","author":"PC Van Poppel","year":"2014","unstructured":"Van Poppel PC, van Asseldonk EJ, Holst JJ et al (2014) The interleukin-1 receptor antagonist anakinra improves first phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance. Diabetes Obes Metab 16(12):1269\u20131273","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1242_CR115","first-page":"573","volume":"51","author":"JR Vane","year":"2000","unstructured":"Vane JR (2000) The fight against rheumatism: from willow bark to Cox-1 sparing drugs. J Physiol Pharmacol 51(4):573\u2013586","journal-title":"J Physiol Pharmacol"},{"key":"1242_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01630479","volume":"44","author":"JR Vane","year":"1995","unstructured":"Vane JR, Botting RM (1995) New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 44:1\u201310","journal-title":"Inflamm Res"},{"issue":"5","key":"1242_CR118","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.2337\/db13-0863","volume":"63","author":"CY Westwell-Roper","year":"2014","unstructured":"Westwell-Roper CY, Ehses JA, Verchere CB (2014) Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1\u03b2 production and \u03b2-cell dysfunction. Diabetes 63(5):1698\u20131711","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"1242_CR119","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/s001250051387","volume":"40","author":"MF White","year":"1997","unstructured":"White MF (1997) The insulin signalling system and the IRS proteins. Diabetologia 40(Suppl. 2):S2\u2013S17","journal-title":"Diabetologia"},{"key":"1242_CR120","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1038\/ncomms4017","volume":"4","author":"B Xiao","year":"2013","unstructured":"Xiao B, Sanders MJ, Carmena D et al (2013) Structural basis of AMPK regulation by small molecule activators. Nat Commun 4:3017","journal-title":"Nat Commun"},{"key":"1242_CR121","doi-asserted-by":"publisher","first-page":"E1211","DOI":"10.1073\/pnas.1321347111","volume":"111","author":"X Xiao","year":"2014","unstructured":"Xiao X, Gaffar I, Guo P et al (2014) M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci USA 111:E1211\u2013E1220","journal-title":"Proc Natl Acad Sci USA"},{"key":"1242_CR123","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)~ kinase-beta. Nature 396:77\u201380","journal-title":"Nature"},{"key":"1242_CR124","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J et al (2001) Reversal of obesity- and diet induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673\u20131677","journal-title":"Science"},{"key":"1242_CR126","first-page":"7457269","volume":"2018","author":"T Zhour","year":"2018","unstructured":"Zhour T, Hu Z, Yang S, Sun L, Uy Z, Wang G (2018) Role of adaptive and innate immunity in type 2 diabetes mellitus. J Diabetes Res 2018:7457269","journal-title":"J Diabetes Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01242-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01242-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01242-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T08:03:06Z","timestamp":1701504186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01242-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01242-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}